Long-term clinical stabilization of scleroderma patients treated with a chronic and intensive IV iloprost regimen. - Wikidata - wikimedia - TriplyDB

Long-term clinical stabilization of scleroderma patients treated with a chronic and intensive IV iloprost regimen.

Long-term clinical stabilization of scleroderma patients treated with a chronic and intensive IV iloprost regimen.

http://www.wikidata.org/entity/Q37601456

about

Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.

P2860

Q39437352-7DC87FF7-0F16-43E6-8DAD-39EEF6EFF902

P2860

Long-term clinical stabilization of scleroderma patients treated with a chronic and intensive IV iloprost regimen.

http://www.wikidata.org/entity/Q37601456

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Long-term clinical stabilizati ...... intensive IV iloprost regimen.

@en

Long-term clinical stabilizati ...... intensive IV iloprost regimen.

@nl

type

label

Long-term clinical stabilizati ...... intensive IV iloprost regimen.

@en

Long-term clinical stabilizati ...... intensive IV iloprost regimen.

@nl

prefLabel

Long-term clinical stabilizati ...... intensive IV iloprost regimen.

@en

Long-term clinical stabilizati ...... intensive IV iloprost regimen.

@nl

P1433

Q37601456-6A3FEC56-AAB6-4D02-A7C3-F66A8B64800B

P1476

Q37601456-507C1DA4-5777-425C-AF28-6A30F857C5EA

P2093

Q37601456-57B4B1F1-D225-46A5-A3D4-B3A2A742206E

Q37601456-6737335C-D26A-447F-8E25-534CCE3B5355

Q37601456-68E374F5-3360-4854-8B98-BE6D0C8E068D

Q37601456-6D96A363-2631-46A6-A257-A9B584EBC109

Q37601456-9857B760-2C6D-4917-A5F9-31FB75638DE7

Q37601456-9AE06FD1-142A-44B9-B21D-A88408B8A943

Q37601456-A6DF5197-A209-4980-B1EB-B5C27E92F9EA

Q37601456-AD93FF57-A627-4705-BAAC-4BC7129ACD8F

Q37601456-DABC8D38-74B6-4EAE-AEF2-12B2170F5DCC

P2860

Q37601456-0224B129-4D54-4DB9-B160-ED1761927080

Q37601456-0CD5BC45-12D3-4CDC-90F7-6A6FFD2F19C8

Q37601456-16AE013B-E92B-4310-A06E-417F07202A00

Q37601456-1AD9C1C4-FC47-497D-9634-DE34CF6E3D37

Q37601456-247DB136-1B9B-425C-ACF7-52DCCB13622D

Q37601456-4E2BA7B9-A21C-453C-BBAF-105C85B8A2D2

Q37601456-5A27353A-0059-43F6-9BB6-E726B61D8FA8

Q37601456-64047384-DFC8-4D04-9FFF-2CD0EB8E1CA1

Q37601456-692573EC-3F7D-43AE-B498-FAF953F137F3

Q37601456-809E8155-CF50-4646-86A6-75C83D7C4CE2

P2888

Q37601456-28ED8ECD-F1A9-44F4-A3F5-63884C0B510F

P304

Q37601456-0221F330-7051-4FFE-9E89-A92DDF05D77D

P31

Q37601456-E27321F3-69D0-41BE-9200-57F68AA40AB6

P356

Q37601456-6643A9F6-23C2-4EC9-9837-D5E99F0471BB

P433

Q37601456-5F92191E-935C-42B3-9126-7100AB4911E1

P478

Q37601456-03A4A249-CCD2-4703-8485-5B80BDC5A2B2

P577

Q37601456-BF05AD3A-1EA3-49C4-A61D-6D774D284C89

P698

Q37601456-8E6671DF-EF35-4535-A864-62B798F8D511

P932

Q37601456-D013C30C-8A4B-4493-9594-A38342C7B733

P356

S00296-016-3582-4

P1433

Rheumatology International

P1476

Long-term clinical stabilizati ...... intensive IV iloprost regimen.

@en

P2093

Alberto Farina

http://www.w3.org/2001/XMLSchema#string

Alessia Benenati

http://www.w3.org/2001/XMLSchema#string

Elisa Visalli

http://www.w3.org/2001/XMLSchema#string

Giorgio Amato

http://www.w3.org/2001/XMLSchema#string

Giovanni Converso

http://www.w3.org/2001/XMLSchema#string

Marcella Di Gangi

http://www.w3.org/2001/XMLSchema#string

Massimiliano Mulè

http://www.w3.org/2001/XMLSchema#string

Rosario Foti

http://www.w3.org/2001/XMLSchema#string

Salvatore Bellofiore

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular function in systemic sclerosis.

Systemic sclerosis/scleroderma: a treatable multisystem disease.

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population.

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.

Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study.

Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension.

A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost.

Severe vascular complications in patients affected by systemic sclerosis cyclically treated with iloprost.

P2888

s00296-016-3582-4

P304

245-249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00296-016-3582-4

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27796521

http://www.w3.org/2001/XMLSchema#string

P932

5258785

http://www.w3.org/2001/XMLSchema#string